NASDAQ · Biotechnology

Aptevo Therapeutics Inc. (APVO) Stock

$1.79 -0.56% NASDAQ: APVO Healthcare

Valuation

MetricValue
Price$1.79
Market Cap$3.91M
P/E Ratio-0.01
P/B Ratio0.36
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$35.64
52-Week Low$1.37
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-201.49%
ROA-181.89%
ROCE-288.14%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.70
Current Ratio3.83

Annual Financials (USD)

Metric20212022202320242025
Revenue$12.0M$3.0M$0$0$0
Operating Profit$-21.0M$-29.0M$-29.0M$-25.0M$-26.0M
Net Profit$-28.0M$8.0M$-17.0M$-24.0M$-26.0M
EPS$-3557646.00$921915.00$-834044.00$-31458.00$-87.27
Op Margin-174.1%-919.8%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$57.0M$34.0M$25.0M$16.0M$27.0M
Total Liabilities$55.0M$16.0M$13.0M$11.0M$10.0M
Cash$45.0M$23.0M$17.0M$9.0M$22.0M
Borrowings$17.0M$10.0M$5.0M$5.0M$5.0M

Latest News

Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors ACCESS Newswire · Jun 30, 2026 APVO: Initiating Coverage of Aptevo Therapeutics Inc.; Unlocking the Next Generation of Multispecific Immune Engagement Zacks Small Cap Research · Jun 16, 2026 Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer ACCESS Newswire · May 28, 2026 Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing ACCESS Newswire · May 27, 2026 All You Need to Know About Aptevo Therapeutics (APVO) Rating Upgrade to Buy Zacks · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-22.0M$-21.0M$-12.0M$-24.0M$-26.0M
Investing Cash Flow$-1.0M$0$0$0$0
Financing Cash Flow$26.0M$3.0M$3.0M$0$0
Net Cash Flow$4.0M$-24.0M$-6.0M$-8.0M$13.0M
Free Cash Flow$-22.0M$-21.0M$-12.0M$-24.0M$-26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.06
FCF Yield-643.82%
Quick Ratio2.08
Interest Coverage0.00
Return 1Y-91.31%
Return 3Y-100.00%
Return 5Y-100.00%

Ownership

Insiders Held7.97%
Institutions Held4.45%
Institutions Float Held4.84%
Institutional HolderSharesReport Date
GSA Capital Partners LLP19,6382026-03-31
Geode Capital Management, LLC13,3372026-03-31
Vanguard Capital Management LLC12,7132026-03-31
Vanguard Fiduciary Trust Co4,1422026-03-31
UBS Group AG3,4452026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABPAbpro Corporation $0.52 — -0.02 $1.06M 0.00%
BCDABioCardia, Inc. $1.04 -1.89% -1.54 $15.48M 0.00%
CEROCERo Therapeutics Holdings, Inc. $0.01 -7.69% 0.00 $14464 0.00%
EPIXESSA Pharma Inc. $0.20 -1.85% -0.87 $9.52M 0.00%
ERNAErnexa Therapeutics Inc. $2.40 -3.61% -0.15 $3.92M 0.00%

About Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. is led by CEO Jeffrey G. Lamothe, employs 37 people, headquartered in US, publicly traded since 2016.

Aptevo Therapeutics Inc. (APVO) stock trades at $1.79 with a market capitalization of $3.91M. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of 0.36, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.37 and $35.64, and currently trades 95.0% below its 52-week high.

On profitability, Aptevo Therapeutics Inc. generates a return on equity (ROE) of -201.49%, return on capital employed of -288.14%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides